Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1/2 2Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1

Conditions

Multiple Myeloma 3Recurrence 1Neoplasms, Plasma Cell 1Neoplasm, Residual 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma, B-Cell 1Leukemia, Myeloid, Acute 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia 1Carcinoma, Hepatocellular 1Amyloidosis 1

Interventions

Dexamethasone 24-(N-methylamino)-4'-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)stilbene 2pomalidomide 1Tacrolimus 1Melphalan 1Lenalidomide 1Hyaluronoglucosaminidase 1Calcium Dobesilate 1Bortezomib 1Antilymphocyte Serum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Amyloidosis × Lenalidomide × Clear all
NCT00890552 2017-03-22

A Pilot Study of Lenalidomide, Melphalan and Dexamethasone in AL Amyloidosis

Stanford University

Phase NA Completed
25 enrolled 12 charts
Other hematologic neoplasmPlasma cell

Amyloidosis, Leukemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡